Name | Walgreens #19278 |
---|---|
Organization Name | Walgreen Co |
Location | 901 Main St, Asbury Park, New Jersey 07712 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (732) 774-5100 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A gene that predicted gigantism in humans was identified in the DNA of the 18th-century man known as the Irish Giant, who was more than 7 feet 7 inches tall. Copies of the same mutation have been found in patients today who suffer from excessive growth, and scientists have concluded they all inherited the gene from a common ancestor.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, presents new data from the Phase 2a trial showing that miravirsen given as a four-week monotherapy treatment provided robust dose-dependent anti-viral activity with a mean reduction of 2 to 3 logs from baseline in HCV RNA (log10 IU/mL) that was maintained for more than four weeks beyond the end of therapy.
Melbourne researchers have discovered that some of the most aggressive forms of cancers can be more effectively treated if chemotherapy is combined with a new class of anti-cancer drugs.
Nastech Pharmaceutical Company has announced receipt of an approvable letter from the U.S. Food and Drug Administration (FDA) on Nascobal (Cyanocobalamin, USP) Nasal Spray for the treatment of vitamin B-12 deficiency.
BD Medical, a segment of BD, today announced the launch of the BD Hyflow™ needle, a unique 27-gauge thin-wall needle designed for use with BD's prefillable syringe systems.
› Verified 4 days ago
NPI Number | 1518076975 |
Organization Name | RITE AID OF NEW JERSEY INC |
Doing Business As | RITE AID PHARMACY 02684 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 901 Main Street, Asbury Park, NJ 07712 |
Phone Number | 732-774-5100 |
News Archive
A gene that predicted gigantism in humans was identified in the DNA of the 18th-century man known as the Irish Giant, who was more than 7 feet 7 inches tall. Copies of the same mutation have been found in patients today who suffer from excessive growth, and scientists have concluded they all inherited the gene from a common ancestor.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, presents new data from the Phase 2a trial showing that miravirsen given as a four-week monotherapy treatment provided robust dose-dependent anti-viral activity with a mean reduction of 2 to 3 logs from baseline in HCV RNA (log10 IU/mL) that was maintained for more than four weeks beyond the end of therapy.
Melbourne researchers have discovered that some of the most aggressive forms of cancers can be more effectively treated if chemotherapy is combined with a new class of anti-cancer drugs.
Nastech Pharmaceutical Company has announced receipt of an approvable letter from the U.S. Food and Drug Administration (FDA) on Nascobal (Cyanocobalamin, USP) Nasal Spray for the treatment of vitamin B-12 deficiency.
BD Medical, a segment of BD, today announced the launch of the BD Hyflow™ needle, a unique 27-gauge thin-wall needle designed for use with BD's prefillable syringe systems.
› Verified 4 days ago
NPI Number | 1982128740 |
Organization Name | WALGREEN CO |
Doing Business As | WALGREENS #19278 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 901 Main St, Asbury Park, NJ 07712 |
Phone Number | 732-774-5100 |
News Archive
A gene that predicted gigantism in humans was identified in the DNA of the 18th-century man known as the Irish Giant, who was more than 7 feet 7 inches tall. Copies of the same mutation have been found in patients today who suffer from excessive growth, and scientists have concluded they all inherited the gene from a common ancestor.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, presents new data from the Phase 2a trial showing that miravirsen given as a four-week monotherapy treatment provided robust dose-dependent anti-viral activity with a mean reduction of 2 to 3 logs from baseline in HCV RNA (log10 IU/mL) that was maintained for more than four weeks beyond the end of therapy.
Melbourne researchers have discovered that some of the most aggressive forms of cancers can be more effectively treated if chemotherapy is combined with a new class of anti-cancer drugs.
Nastech Pharmaceutical Company has announced receipt of an approvable letter from the U.S. Food and Drug Administration (FDA) on Nascobal (Cyanocobalamin, USP) Nasal Spray for the treatment of vitamin B-12 deficiency.
BD Medical, a segment of BD, today announced the launch of the BD Hyflow™ needle, a unique 27-gauge thin-wall needle designed for use with BD's prefillable syringe systems.
› Verified 4 days ago
News Archive
A gene that predicted gigantism in humans was identified in the DNA of the 18th-century man known as the Irish Giant, who was more than 7 feet 7 inches tall. Copies of the same mutation have been found in patients today who suffer from excessive growth, and scientists have concluded they all inherited the gene from a common ancestor.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, presents new data from the Phase 2a trial showing that miravirsen given as a four-week monotherapy treatment provided robust dose-dependent anti-viral activity with a mean reduction of 2 to 3 logs from baseline in HCV RNA (log10 IU/mL) that was maintained for more than four weeks beyond the end of therapy.
Melbourne researchers have discovered that some of the most aggressive forms of cancers can be more effectively treated if chemotherapy is combined with a new class of anti-cancer drugs.
Nastech Pharmaceutical Company has announced receipt of an approvable letter from the U.S. Food and Drug Administration (FDA) on Nascobal (Cyanocobalamin, USP) Nasal Spray for the treatment of vitamin B-12 deficiency.
BD Medical, a segment of BD, today announced the launch of the BD Hyflow™ needle, a unique 27-gauge thin-wall needle designed for use with BD's prefillable syringe systems.
› Verified 4 days ago
Walgreens #19278 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 901 Main St, Asbury Park, New Jersey 07712 Phone: (732) 774-5100 |